To justify the impact of reduced COX2 on megakaryocytes in ITP, we evaluated megakaryocyte maturation and thrombopoiesis both in vivo and in vitro using COX2 inhibitors. Here, PTGS2 is linked to autoimmune thrombocytopenic purpura.